2021-001026-22
This Study Will Evaluate the Safety, Tolerability, Activity of the Drug in the Body and Effectiveness of Baloxavir Marboxil Given as Granules in a Single Dose to Otherwise Healthy Children with Influenza
Shionogi & Co., Ltd.·EU Clinical Trials Register
Study focus
- Disease/Condition
- Influenza
Sponsor & location
- Primary sponsor
- Shionogi & Co., Ltd.
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
Time to alleviation of influenza illness
ICD-10 classifications
Influenza and pneumoniaInfluenza due to identified seasonal influenza virusInfluenza with other manifestations, seasonal influenza virus identifiedInfluenza with pneumonia, seasonal influenza virus identifiedInfluenza due to identified zoonotic or pandemic influenza virus
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2021-001026-22
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2021-001026-22 through Pure Global AI's free database. This phase not specified trial is sponsored by Shionogi & Co., Ltd. and is currently status unknown. The study focuses on Influenza.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.